Verified email-pattern data for Bolder Biotechnology is currently limited. You can still use the company insights and contact sections below.
Bolder BioTechnology, Inc. is a private company that uses advanced protein engineering and bioconjugation technologies to create easier to use, safer and more cost-effective human protein pharmaceuticals.
Company Details
- Address
- 2425 55th St,
- Industry
- Biotechnology Research
- Website
- http://www.bolderbio.com
- HQ
- Boulder, Colorado
Bolder Biotechnology Questions
Bolder BioTechnology's website is http://www.bolderbio.com
Bolder BioTechnology's LinkedIn profile is https://www.linkedin.com/company/bolder-biotechnology
Bolder BioTechnology's industry is
Biotechnology Research
Bolder BioTechnology's top competitors are
Viridian Therapeutics, Inc.,
Enliven Therapeutics,
Levana Biologics - A Biotechnology Company,
Enveda,
Elk Biotechnology,
Neurexis Therapeutics,
Muse Biotechnology Inc,
Clovis Oncology,
Edgewise Therapeutics,
Coswald Pharmaceutical/biotechnology Consulting Llc.
Bolder BioTechnology's categories are Biotechnology Research
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.